13C/15N‐Enriched l‐Dopa as a Triple‐Resonance NMR Probe to Monitor Neurotransmitter Dopamine in the Brain and Liver Extracts of Mice

Authors:

Abstract
In an attempt to monitor μm‐level trace constituents, we applied here 1H‐{13C‐15N} triple‐resonance nuclear magnetic resonance (NMR) to 13C/15N‐enriched l‐Dopa as the inevitable precursor of the neurotransmitter dopamine in the brain. The perfect selectivity (to render endogenous components silent) and μm‐level sensitivity (700 MHz spectrometer equipped with a cryogenic probe) of triple‐resonance allowed the unambiguous and quantitative metabolic and pharmacokinetic analyses of administered l‐Dopa/dopamine in the brain and liver of mice. The level of dopamine generated in the brain (within the range 7–76 μm, which covers the typical stimulated level of ∼30 μm) could be clearly monitored ex vivo, but was slightly short of the detection limit of a 7 T MR machine for small animals. This work suggests that μm‐level trace constituents are potential targets of ex vivo monitoring as long as they contain N atom(s) and their appropriate 13C/15N‐enrichment is synthetically accessible.
Funding Information
  • Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems
  • Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) (25350977, 15K01819, 15H01403)
  • JSPS
  • Daiwa Securities Health Foundation
  • Princess Takamatsu Cancer Research Fund
  • Magnetic Health Science Foundation
  • SEI Group CSR Foundation

This publication has 29 references indexed in Scilit: